Low Postnatal Levels of Arachidonic Acid Linked to ROP

Share this content:
Low Postnatal Levels of Arachidonic Acid Linked to ROP
Low Postnatal Levels of Arachidonic Acid Linked to ROP

MONDAY, Feb. 12, 2018 (HealthDay News) -- For infants born at a gestational age (GA) of less than 28 weeks, low postnatal levels of arachidonic acid (AA) are associated with developing retinopathy of prematurity (ROP), according to a study published online Feb. 8 in JAMA Ophthalmology.

Chatarina A. Löfqvist, Ph.D., from the University of Gothenburg in Sweden, and colleagues examined the risk of ROP in association with levels of circulating ω-3 and ω-6 long chain-polyunsaturated fatty acids in a cohort of 90 infants born at a GA of less than 28 weeks. Cord blood samples and venous blood samples were obtained at birth and at one, seven, 14, and 28 days after birth, and at postmenstrual age (PMA) of 32, 36, and 40 weeks.

The researchers found that infants with a later diagnosis of ROP had lower area under the curve of AA (20:4 ω-6) versus infants with no ROP in the first month of life (mean, 34.05 versus 37.15). Infants with later severe ROP had lower levels of AA at 32 weeks' PMA compared to those without ROP (mean, 7.06 versus 8.74). Low postnatal serum levels of AA and GA at birth identified infants who developed ROP with a sensitivity >90 percent.

"Evaluating postnatal AA fraction after birth in addition to GA may be useful for ROP prediction," the authors write.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Many Foster Kids Inappropriately Prescribed Psychiatric Drugs

Many Foster Kids Inappropriately Prescribed Psychiatric Drugs

Some children may be getting meds they don't need, others may be going without drugs that may help

FDA Approves Device for Acute Coronary Artery Perforations

FDA Approves Device for Acute Coronary Artery Perforations

The PK Papyrus device is a balloon-expandable covered coronary stent and delivery system

Decrease in Infant Walker-Related Injuries Since 2010

Decrease in Infant Walker-Related Injuries Since 2010

Decrease in injuries following implementation of federal mandatory safety standard in 2010

is free, fast, and customized just for you!




Already a member?

Sign In Now »